Hims & Hers and other telehealth providers say employers that balked at pricey brand-name shots are investigating cheaper off ...

While some GLP-1s are approved for patients age 12 and older, only a few telehealth companies will prescribe them to children ...

Geoff Cook, CEO of Noom, sits down with Nasdaq's Kristina Ayanian to discuss Noom's mission to help as many people as possible live healthier lives through behavior change. Sign up for our ...

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced that ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet and behaviours, and executive chair and former CEO Saeju Jeong said the ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Al Roker opened up about food addiction and the use of trendy weight loss medications, admitting that he won’t judge those ...

Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill.